melphalan melphalan


  • (n) antineoplastic drug (trade name Alkeran) used to treat multiple myeloma and some other malignancies


  1. CE Melphalan meets Phase 2 primary endpoint

    Spectrum Pharmaceuticals' ( SPPI ) conditioning treatment in autologous transplants in multiple myeloma, Captisol-enabled (propylene glycol-free) Melphalan ( CE Melphalan ) meets its primary endpoint of determining the overall safety and toxicity profile in multiple myeloma patients receiving 200mg/m2 of CE Melphalan as myeloablative therapy prior to autologous stem cell transplantation ...
    on April 23, 2014     Source: Seeking Alpha

  2. Ligand's partner Spectrum says Captisol-enabled melphalan meets primary endpoint

    Ligand Pharmaceuticals (LGND) announces that its Captisol-enabled Melphalan development and commercial partner Spectrum Pharmaceuticals (SPPI) has reported that their pivotal trial of CE Melphalan met ...
    on April 23, 2014     Source: via Yahoo! Finance

  3. Ligand’s Partner Spectrum Pharmaceuticals Reports Captisol-Enabled Melphalan Meets Primary Endpoint in Pivotal Trial

    Ligand Pharmaceuticals Incorporated announces that its Captisol-enabled™ Melphalan development and commercial partner Spectrum
    on April 23, 2014     Source: Business Wire via Yahoo! Finance

Word of the Day
infatuated infatuated
/ɪn ˈfæ tʃu ˌeɪ tɪd /